Setting of an import tolerance for fenazaquin in teas.

Authors

European Food Safety Authority (EFSA), Giulia Bellisai, Giovanni Bernasconi, Irene Castellan, Monica Del Aguila, Lucien Ferreira, Renata Leuschner, Andrea Mioč, Marta Szot, Manuela Tiramani, Alessia Verani

Published in

EFSA journal. European Food Safety Authority. Volume 24. Issue 9. Pages e10306. Epub Sep 10, 2026.

Abstract

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Gowan Crop Protection Limited submitted a request to the competent national authority in Germany to set an import tolerance for the active substance fenazaquin in teas imported from India. The results of the four new residue trials submitted in support of the request, together with those previously assessed during the maximum residue level (MRL) review for the same import tolerance, on the basis of which a tentative MRL of 9 mg/kg was set, are sufficient to derive an MRL for teas at the same level. The enforcement analytical method and its independent laboratory validation (ILV) submitted were found to be adequate to control fenazaquin residues in the commodity under consideration at the validated limit of quantification (LOQ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues of fenazaquin and its toxicologically relevant plant metabolite 2-(4-tert-butylphenyl) ethanol (TBPE) resulting from the use of fenazaquin on teas imported from India according to the reported agricultural practice is unlikely to present a risk to consumer health. The consumer risk assessment for TBPE is indicative only, due to uncertainties related to missing residue data for this metabolite in commodities covered by EU-implemented Codex maximum residue limit (CXLs). Risk managers may consider either confirming the existing MRL of 9 mg/kg or lowering the value to 3 mg/kg, in line with the MRL currently in force in the country of origin.

PMID:
42724559
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.